Sam Brusco, Associate Editor08.17.23
Modular Medical, a development-stage insulin delivery tech firm, began a collaboration with Phillips-Medisize. Phillips-Medisize will provide Modular Medical with design, development, and high-volume manufacturing capabilities for its next-gen, affordable insulin pump technology.
Phillips-Medisize used its global, diversified supplier base and medical device and diabetes disease experience to build manufacturing and assembly for the MODD1 insulin delivery system. The company provided two-shot and insert injection molding, as well as packaging, electronics design and manufacturing, and assembly operations.
"This collaboration has provided Modular Medical with an accelerated development process, while simultaneously preparing for significant scalability and market launch readiness," Kevin Schmid, COO of Modular Medical told the press. "Phillips-Medisize brought engineering resources, insulin delivery materials and medical manufacturing knowledge, while providing supply chain expertise, to enable Modular Medical to scale rapidly and seamlessly to meet anticipated consumer demand. The collaboration is preparing Modular Medical to quickly market its new delivery technology for insulin-requiring patients with diabetes."
"Through this collaboration, we were able to meet Modular Medical's aggressive development schedule to commercialize the MODD1 Insulin Delivery System, a patient-centric innovation designed to support critical treatment for the growing number of patients who rely upon insulin to manage their diabetes," added John Horgan, vice president and general manager, Global Medical Business Unit, at Phillips-Medisize. "Our team was honored to be part of the development of a product that will make a meaningful difference in patients' quality of life."
Modular Medical was founded by medical device professional and microfluidics engineer Paul DiPerna. Before founding it, he was found of Tandem Diabetes and designed its t:slim insulin pump.
Phillips-Medisize used its global, diversified supplier base and medical device and diabetes disease experience to build manufacturing and assembly for the MODD1 insulin delivery system. The company provided two-shot and insert injection molding, as well as packaging, electronics design and manufacturing, and assembly operations.
"This collaboration has provided Modular Medical with an accelerated development process, while simultaneously preparing for significant scalability and market launch readiness," Kevin Schmid, COO of Modular Medical told the press. "Phillips-Medisize brought engineering resources, insulin delivery materials and medical manufacturing knowledge, while providing supply chain expertise, to enable Modular Medical to scale rapidly and seamlessly to meet anticipated consumer demand. The collaboration is preparing Modular Medical to quickly market its new delivery technology for insulin-requiring patients with diabetes."
"Through this collaboration, we were able to meet Modular Medical's aggressive development schedule to commercialize the MODD1 Insulin Delivery System, a patient-centric innovation designed to support critical treatment for the growing number of patients who rely upon insulin to manage their diabetes," added John Horgan, vice president and general manager, Global Medical Business Unit, at Phillips-Medisize. "Our team was honored to be part of the development of a product that will make a meaningful difference in patients' quality of life."
Modular Medical was founded by medical device professional and microfluidics engineer Paul DiPerna. Before founding it, he was found of Tandem Diabetes and designed its t:slim insulin pump.